| COVID-19 Vaccine |
1 |
1 |
| Child |
0 |
0.8 |
| Vaccines |
0 |
0.9 |
| Patient Safety |
0 |
0.4 |
| Food and Drug Administration (FDA) |
0 |
0.5 |
| COVID-19 |
0 |
0.6 |
| Health Care Quality, Access, and Evaluation |
0 |
0.5 |
| Social Determinants of Health |
0 |
0.09 |
| Adolescent Medicine |
0 |
0.06 |
| Adverse Effects |
0 |
0.06 |
| Cardiomyopathy |
0 |
0.06 |
| Immunization |
0 |
0.06 |
| Myocarditis |
0 |
0.06 |
| New York |
0 |
0.06 |
| Young Adult |
0 |
0.06 |
| Ethics |
0 |
0.05 |
| Bioethics |
0 |
0.03 |
| Biomarker |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Health Care Services |
0 |
0.03 |
| Heart |
0 |
0.03 |
| Id Reaction |
0 |
0.03 |
| Immunology |
0 |
0.03 |
| Maryland |
0 |
0.03 |
| Michigan |
0 |
0.03 |
| Microbiology |
0 |
0.03 |
| Minnesota |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Pandemic |
0 |
0.03 |
| Pericarditis |
0 |
0.03 |
| T-Lymphocyte |
0 |
0.03 |
| Utah |
0 |
0.03 |
| Dermatitis |
0 |
0.02 |
| Microbiome |
0 |
0.02 |